{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:41:21Z","timestamp":1785796881026,"version":"3.56.0"},"reference-count":65,"publisher":"American Association for Cancer Research (AACR)","issue":"8","license":[{"start":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T00:00:00Z","timestamp":1692316800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"HHS | NIH | National Cancer Institute","award":["F31 CA265219"],"award-info":[{"award-number":["F31 CA265219"]}]},{"name":"HHS | NIH | National Cancer Institute","award":["R01 CA163566"],"award-info":[{"award-number":["R01 CA163566"]}]},{"name":"HHS | NIH | National Cancer Institute","award":["R41CA228695"],"award-info":[{"award-number":["R41CA228695"]}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,8,18]]},"abstract":"<jats:p>Despite recent therapeutic advances, the 5-year survival rate for adults with acute myeloid leukemia (AML) is poor and standard-of-care chemotherapy is associated with significant toxicity, highlighting the need for new therapeutic approaches. Recent work from our group and others established that the G protein-coupled estrogen receptor (GPER) is tumor suppressive in melanoma and other solid tumors. We performed a preliminary screen of human cancer cell lines from multiple malignancies and found that LNS8801, a synthetic pharmacologic agonist of GPER currently in early phase clinical trials, promoted apoptosis in human AML cells. Using human AML cell lines and primary cells, we show that LNS8801 inhibits human AML in preclinical in vitro models, while not affecting normal mononuclear cells. Although GPER is broadly expressed in normal and malignant myeloid cells, this cancer-specific LNS8801-induced inhibition appeared to be independent of GPER signaling. LNS8801 induced AML cell death primarily through a caspase-dependent apoptosis pathway. This was independent of secreted classical death receptor ligands, and instead required induction of reactive oxygen species (ROS) and activation of endoplasmic reticulum (ER) stress response pathways including IRE1\u03b1. These studies demonstrate a novel activity of LNS8801 in AML cells and show that targeting ER stress with LNS8801 may be a useful therapeutic approach for AML.<\/jats:p>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Previous work demonstrated that LNS8801 inhibits cancer via GPER activation, especially in solid tumors. Here we show that LNS8801 inhibits AML via GPER-independent mechanisms that include ROS induction and ER activation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-22-0478","type":"journal-article","created":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T08:53:54Z","timestamp":1689756834000},"page":"1594-1606","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["LNS8801 inhibits Acute Myeloid Leukemia by Inducing the Production of Reactive Oxygen Species and Activating the Endoplasmic Reticulum Stress Pathway"],"prefix":"10.1158","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8406-1801","authenticated-orcid":true,"given":"Inyoung","family":"Lee","sequence":"first","affiliation":[{"name":"1Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9736-2651","authenticated-orcid":true,"given":"Miriam","family":"Doepner","sequence":"additional","affiliation":[{"name":"1Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8096-5421","authenticated-orcid":true,"given":"Jillian","family":"Weissenrieder","sequence":"additional","affiliation":[{"name":"2Department of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5301-8720","authenticated-orcid":true,"given":"Ariana D.","family":"Majer","sequence":"additional","affiliation":[{"name":"1Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0504-493X","authenticated-orcid":true,"given":"Sophia","family":"Mercado","sequence":"additional","affiliation":[{"name":"1Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3393-8148","authenticated-orcid":true,"given":"Angela","family":"Estell","sequence":"additional","affiliation":[{"name":"1Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4949-3849","authenticated-orcid":true,"given":"Christopher A.","family":"Natale","sequence":"additional","affiliation":[{"name":"1Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania."},{"name":"3Linnaeus Therapeutics, Haddonfield, New Jersey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5828-5622","authenticated-orcid":true,"given":"Pamela J.","family":"Sung","sequence":"additional","affiliation":[{"name":"4Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New Jersey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8854-0268","authenticated-orcid":true,"given":"J. Kevin","family":"Foskett","sequence":"additional","affiliation":[{"name":"2Department of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5622-3735","authenticated-orcid":true,"given":"Martin P.","family":"Carroll","sequence":"additional","affiliation":[{"name":"5Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8482-1284","authenticated-orcid":true,"given":"Todd W.","family":"Ridky","sequence":"additional","affiliation":[{"name":"1Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2023,8,18]]},"reference":[{"key":"2023081814072267800_bib1","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra1406184","article-title":"Acute myeloid leukemia","volume":"373","author":"D\u00f6hner","year":"2015","journal-title":"N Engl J Med"},{"key":"2023081814072267800_bib2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/ajh.24246","article-title":"Acute myeloid leukemia\u2013major progress over four decades and glimpses into the future","volume":"91","author":"Kantarjian","year":"2016","journal-title":"Am J Hematol"},{"key":"2023081814072267800_bib3","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1182\/blood-2008-07-172007","article-title":"Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry","volume":"113","author":"Juliusson","year":"2009","journal-title":"Blood"},{"key":"2023081814072267800_bib4","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1182\/blood.V98.5.1302","article-title":"Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial","volume":"98","author":"Goldstone","year":"2001","journal-title":"Blood"},{"key":"2023081814072267800_bib5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1365-2141.2001.03043.x","article-title":"Prognostic significance of risk group stratification in elderly patients with acute myeloid leukaemia","volume":"115","author":"Wahlin","year":"2001","journal-title":"Br J Haematol"},{"key":"2023081814072267800_bib6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/cncr.22779","article-title":"Intensive chemotherapy is not recommended for patients aged &gt;60 years who have myelodysplastic syndromes or acute myeloid leukemia with high-risk karyotypes","volume":"110","author":"Knipp","year":"2007","journal-title":"Cancer"},{"key":"2023081814072267800_bib7","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1182\/blood-2005-09-3724","article-title":"Age and acute myeloid leukemia","volume":"107","author":"Appelbaum","year":"2006","journal-title":"Blood"},{"key":"2023081814072267800_bib8","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1056\/NEJMoa0901409","article-title":"High-dose daunorubicin in older patients with acute myeloid leukemia","volume":"361","author":"L\u00f6wenberg","year":"2009","journal-title":"N Engl J Med"},{"key":"2023081814072267800_bib9","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/ajh.25620","article-title":"Maintenance therapy in AML: the past, the present and the future","volume":"94","author":"Molica","year":"2019","journal-title":"Am J Hematol"},{"key":"2023081814072267800_bib10","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1158\/2159-8290.CD-16-0313","article-title":"Efficacy and biological correlates of response in a phase II study of venetoclax monotherapy in patients with acute myelogenous leukemia","volume":"6","author":"Konopleva","year":"2016","journal-title":"Cancer Discov"},{"key":"2023081814072267800_bib11","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1182\/blood.V128.22.1651.1651","article-title":"A phase 1 clinical trial of selinexor in combination with decitabine in patients with newly diagnosed and relapsed or refractory acute myeloid leukemia","volume":"128","author":"Bhatnagar","year":"2016","journal-title":"Blood"},{"key":"2023081814072267800_bib12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41594-017-0011-7","article-title":"Structure and dynamics of GPCR signaling complexes","volume":"25","author":"Hilger","year":"2018","journal-title":"Nat Struct Mol Biol"},{"key":"2023081814072267800_bib13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrc2069","article-title":"G-protein-coupled receptors and cancer","volume":"7","author":"Dorsam","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"2023081814072267800_bib14","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1002\/1873-3468.14017","article-title":"Protein-coupled receptors and heterotrimeric G proteins as cancer drivers","volume":"594","author":"Arang","year":"2020","journal-title":"FEBS Lett"},{"key":"2023081814072267800_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrd.2016.230","article-title":"A comprehensive map of molecular drug targets","volume":"16","author":"Santos","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"2023081814072267800_bib16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cellsig.2017.09.005","article-title":"GPCRs: emerging anti-cancer drug targets","volume":"41","author":"Gutierrez","year":"2018","journal-title":"Cell Signal"},{"key":"2023081814072267800_bib17","doi-asserted-by":"crossref","first-page":"e431","DOI":"10.1038\/bcj.2016.36","article-title":"Transcriptome analysis of G protein-coupled receptors in distinct genetic subgroups of acute myeloid leukemia: identification of potential disease-specific targets","volume":"6","author":"Maiga","year":"2016","journal-title":"Blood Cancer J"},{"key":"2023081814072267800_bib18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.trsl.2019.05.004","article-title":"Characterization of upregulated adhesion GPCRs in acute myeloid leukemia","volume":"212","author":"Yang","year":"2019","journal-title":"Transl Res"},{"key":"2023081814072267800_bib19","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.neo.2020.09.005","article-title":"ONC201 and imipridones: anti-cancer compounds with clinical efficacy","volume":"22","author":"Prabhu","year":"2020","journal-title":"Neoplasia"},{"key":"2023081814072267800_bib20","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1038\/s41375-019-0491-z","article-title":"Imipridone ONC212 activates orphan G protein-coupled receptor GPR132 and integrated stress response in acute myeloid leukemia","volume":"33","author":"Nii","year":"2019","journal-title":"Leukemia"},{"key":"2023081814072267800_bib21","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00432-014-1598-2","article-title":"GPER functions as a tumor suppressor in MCF-7 and SK-BR-3 breast cancer cells","volume":"140","author":"Wei\u00dfenborn","year":"2014","journal-title":"J Cancer Res Clin Oncol"},{"key":"2023081814072267800_bib22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1757-2215-6-51","article-title":"GPER-1 acts as a tumor suppressor in ovarian cancer","volume":"6","author":"Ignatov","year":"2013","journal-title":"J Ovarian Res"},{"key":"2023081814072267800_bib23","doi-asserted-by":"crossref","first-page":"638171","DOI":"10.3389\/fonc.2021.638171","article-title":"GPER-Induced ERK signaling decreases cell viability of hepatocellular carcinoma","volume":"11","author":"Qiu","year":"2021","journal-title":"Front Oncol"},{"key":"2023081814072267800_bib24","doi-asserted-by":"crossref","first-page":"647","DOI":"10.5483\/BMBRep.2019.52.11.007","article-title":"G protein-coupled estrogen receptor-1 agonist induces chemotherapeutic effect via ER stress signaling in gastric cancer","volume":"52","author":"Lee","year":"2019","journal-title":"BMB Rep"},{"key":"2023081814072267800_bib25","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.12659\/MSM.913634","article-title":"Downregulation of G protein-coupled estrogen receptor (GPER) is associated with reduced prognosis in patients with gastric cancer","volume":"25","author":"Tian","year":"2019","journal-title":"Med Sci Monit"},{"key":"2023081814072267800_bib26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.steroids.2013.10.017","article-title":"Vasodilation by GPER in mesenteric arteries involves both endothelial nitric oxide and smooth muscle cAMP signaling","volume":"81","author":"Lindsey","year":"2014","journal-title":"Steroids"},{"key":"2023081814072267800_bib27","doi-asserted-by":"crossref","first-page":"E398","DOI":"10.1152\/ajpendo.00534.2013","article-title":"G protein-coupled estrogen receptor 1 mediates relaxation of coronary arteries via cAMP\/PKA-dependent activation of MLCP","volume":"307","author":"Yu","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2023081814072267800_bib28","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.lfs.2012.01.007","article-title":"GPER regulates endothelin-dependent vascular tone and intracellular calcium","volume":"91","author":"Meyer","year":"2012","journal-title":"Life Sci"},{"key":"2023081814072267800_bib29","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1210\/en.2011-0091","article-title":"Mechanisms of estradiol-induced insulin secretion by the G protein-coupled estrogen receptor GPR30\/GPER in pancreatic \u03b2-cells","volume":"152","author":"Sharma","year":"2011","journal-title":"Endocrinology"},{"key":"2023081814072267800_bib30","doi-asserted-by":"crossref","first-page":"e31770","DOI":"10.7554\/eLife.31770","article-title":"Activation of G protein-coupled estrogen receptor signaling inhibits melanoma and improves response to immune checkpoint blockade","volume":"7","author":"Natale","year":"2018","journal-title":"Elife"},{"key":"2023081814072267800_bib31","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2021.39.15_suppl.3084","article-title":"Phase 1 trial of a novel, first-in-class G protein-coupled estrogen receptor (GPER) agonist, LNS8801, in patients with advanced or recurrent treatment-refractory solid malignancies","volume":"39","author":"Muller","year":"2021","journal-title":"J Clin Oncol"},{"key":"2023081814072267800_bib32","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.jcmgh.2020.04.016","article-title":"Pharmacologic activation of the G protein\u2013coupled estrogen receptor inhibits pancreatic ductal adenocarcinoma","volume":"10","author":"Natale","year":"2020","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2023081814072267800_bib33","doi-asserted-by":"crossref","first-page":"811479","DOI":"10.3389\/fcell.2022.811479","article-title":"The G-protein\u2013coupled estrogen receptor agonist G-1 inhibits proliferation and causes apoptosis in leukemia cell lines of T lineage","volume":"10","author":"Torres-L\u00f3pez","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"2023081814072267800_bib34","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/s41419-022-05357-9","article-title":"Targeted activation of GPER enhances the efficacy of venetoclax by boosting leukemic pyroptosis and Cd8 + T cell immune function in acute myeloid leukemia","volume":"13","author":"Ren","year":"2022","journal-title":"Cell Death Dis"},{"key":"2023081814072267800_bib35","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nchembio775","article-title":"Virtual and biomolecular screening converge on a selective agonist for GPR30","volume":"2","author":"Bologa","year":"2006","journal-title":"Nat Chem Biol"},{"key":"2023081814072267800_bib36","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jsbmb.2011.07.002","article-title":"Identification of a GPER\/GPR30 antagonist with improved estrogen receptor counterselectivity","volume":"127","author":"Dennis","year":"2011","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2023081814072267800_bib37","doi-asserted-by":"crossref","first-page":"6490","DOI":"10.3390\/ijms21186490","article-title":"G protein-coupled estrogen receptor mediates cell proliferation through the cAMP\/PKA\/CREB pathway in murine bone marrow mesenchymal stem cells","volume":"21","author":"Chuang","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2023081814072267800_bib38","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3389\/fnmol.2018.00255","article-title":"cAMP response element-binding protein (CREB): a possible signaling molecule link in the pathophysiology of schizophrenia","volume":"11","author":"Wang","year":"2018","journal-title":"Front Mol Neurosci"},{"key":"2023081814072267800_bib39","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1210\/en.2004-1064","article-title":"Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells","volume":"146","author":"Thomas","year":"2005","journal-title":"Endocrinology"},{"key":"2023081814072267800_bib40","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3389\/fnins.2019.01351","article-title":"Activation of the G protein-coupled estrogen receptor elicits store calcium release and phosphorylation of the mu-opioid receptors in the human neuroblastoma SH-SY5Y cells","volume":"13","author":"Ding","year":"2019","journal-title":"Front Neurosci"},{"key":"2023081814072267800_bib41","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","article-title":"Apoptosis: a review of programmed cell death","volume":"35","author":"Elmore","year":"2007","journal-title":"Toxicol Pathol"},{"key":"2023081814072267800_bib42","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41419-020-2379-2","article-title":"MCL1 inhibition is effective against a subset of small-cell lung cancer with high MCL1 and low BCL-XL expression","volume":"11","author":"Yasuda","year":"2020","journal-title":"Cell Death Dis"},{"key":"2023081814072267800_bib43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41419-017-0035-2","article-title":"MCL-1 is a prognostic indicator and drug target in breast cancer article","volume":"9","author":"Campbell","year":"2018","journal-title":"Cell Death Dis"},{"key":"2023081814072267800_bib44","doi-asserted-by":"crossref","first-page":"10853","DOI":"10.1073\/pnas.0804821105","article-title":"mTORC1 promotes survival through translational control of Mcl-1","volume":"105","author":"Mills","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023081814072267800_bib45","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1101\/gad.182980.111","article-title":"Anti-apoptotic mcl-1 is essential for the development and sustained growth of acute myeloid leukemia","volume":"26","author":"Glaser","year":"2012","journal-title":"Genes Dev"},{"key":"2023081814072267800_bib46","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nature19830","article-title":"The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models","volume":"538","author":"Kotschy","year":"2016","journal-title":"Nature"},{"key":"2023081814072267800_bib47","doi-asserted-by":"crossref","first-page":"668617","DOI":"10.3389\/fonc.2021.668617","article-title":"G protein-coupled estrogen receptor agonist G-1 inhibits mantle cell lymphoma growth in preclinical models","volume":"11","author":"Zhou","year":"2021","journal-title":"Front Oncol"},{"key":"2023081814072267800_bib48","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1182\/blood-2010-07-294827","article-title":"The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML","volume":"118","author":"Zhou","year":"2011","journal-title":"Blood"},{"key":"2023081814072267800_bib49","doi-asserted-by":"crossref","first-page":"e2797","DOI":"10.1038\/cddis.2017.176","article-title":"Disulfiram\/copper selectively eradicates AML leukemia stem cells in vitro and in vivo by simultaneous induction of ROS-JNK and inhibition of NF-\u03baB and Nrf2","volume":"8","author":"Xu","year":"2017","journal-title":"Cell Death Dis"},{"key":"2023081814072267800_bib50","doi-asserted-by":"crossref","first-page":"12635","DOI":"10.3390\/ijms222312635","article-title":"N-acetylcysteine can induce massive oxidative stress, resulting in cell death with apoptotic features in human leukemia cells","volume":"22","author":"Mlejnek","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2023081814072267800_bib51","doi-asserted-by":"crossref","first-page":"6626","DOI":"10.3892\/mmr.2017.7442","article-title":"N-acetylcysteine induces apoptosis via the mitochondria-dependent pathway but not via endoplasmic reticulum stress in H9c2 cells","volume":"16","author":"Liu","year":"2017","journal-title":"Mol Med Rep"},{"key":"2023081814072267800_bib52","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1089\/ars.2007.1782","article-title":"Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword?","volume":"9","author":"Malhotra","year":"2007","journal-title":"Antioxid Redox Signal"},{"key":"2023081814072267800_bib53","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.molcel.2009.10.021","article-title":"GM1-ganglioside accumulation at the mitochondria-associated ER membranes links ER stress to Ca2+-dependent mitochondrial apoptosis","volume":"36","author":"Sano","year":"2009","journal-title":"Mol Cell"},{"key":"2023081814072267800_bib54","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1038\/cdd.2012.74","article-title":"PERK is required at the ER-mitochondrial contact sites to convey apoptosis after ROS-based ER stress","volume":"19","author":"Verfaillie","year":"2012","journal-title":"Cell Death Differ"},{"key":"2023081814072267800_bib55","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3390\/biom9090503","article-title":"G-protein-coupled estrogen receptor (GPER)-specific agonist G1 induces ER stress leading to cell death in MCF-7 cells","volume":"9","author":"Vo","year":"2019","journal-title":"Biomolecules"},{"key":"2023081814072267800_bib56","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/sj.embor.7400779","article-title":"Mediators of endoplasmic reticulum stress-induced apoptosis","volume":"7","author":"Szegezdi","year":"2006","journal-title":"EMBO Rep"},{"key":"2023081814072267800_bib57","doi-asserted-by":"crossref","first-page":"8326","DOI":"10.1073\/pnas.0903197106","article-title":"Sustained activation of XBP1 splicing leads to endothelial apoptosis and atherosclerosis development in response to disturbed flow","volume":"106","author":"Zeng","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023081814072267800_bib58","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1128\/MCB.21.4.1249-1259.2001","article-title":"Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state","volume":"21","author":"McCullough","year":"2001","journal-title":"Mol Cell Biol"},{"key":"2023081814072267800_bib59","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1158\/2767-9764.CRC-22-0399","article-title":"The GPER agonist LNS8801 induces mitotic arrest and apoptosis in uveal melanoma cells","volume":"3","author":"Ambrosini","year":"2023","journal-title":"Cancer Res Commun"},{"key":"2023081814072267800_bib60","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pharmthera.2011.08.001","article-title":"G protein-coupled receptor kinases: more than just kinases and not only for GPCRs","volume":"133","author":"Gurevich","year":"2012","journal-title":"Pharmacol Ther"},{"key":"2023081814072267800_bib61","article-title":"IND-enabling characterization of the selective GPER agonist, LNS8801 [abstract]","author":"Natale","year":"2021"},{"key":"2023081814072267800_bib62","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/B978-0-12-407869-7.00009-X","article-title":"Visceral fat and hypertension: sex differences","volume-title":"Nutrition in the prevention and treatment of abdominal obesity","author":"Pausova","year":"2014"},{"key":"2023081814072267800_bib63","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/bloodadvances.2018029850","article-title":"Hematopoietic cytokines mediate resistance to targeted therapy in FLT3-ITD acute myeloid leukemia","volume":"3","author":"Sung","year":"2019","journal-title":"Blood Adv"},{"key":"2023081814072267800_bib64","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.exphem.2016.02.003","article-title":"Chemosensitizing AML cells by targeting bone marrow endothelial cells","volume":"44","author":"Bosse","year":"2016","journal-title":"Exp Hematol"},{"key":"2023081814072267800_bib65","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2022.40.16_suppl.2574","article-title":"Phase 1b study of the novel first-in-class G protein-coupled estrogen receptor (GPER) agonist, LNS8801, in combination with pembrolizumab in patients with immune checkpoint inhibitor (ICI)-relapsed and refractory solid malignancies and dose escalation update","volume":"40","author":"Muller","year":"2022","journal-title":"J Clin Oncol"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-22-0478\/3348441\/crc-22-0478.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/3\/8\/1594\/3356415\/crc-22-0478.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/3\/8\/1594\/3356415\/crc-22-0478.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T10:21:13Z","timestamp":1692354073000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/3\/8\/1594\/728473\/LNS8801-inhibits-Acute-Myeloid-Leukemia-by"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,18]]},"references-count":65,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8,18]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-22-0478","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.23709424","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709400","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989212","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989179","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709394","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989215.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989185.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989182","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709388","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709421","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989176","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709403.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709409.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989209","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709424.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709415.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709391","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989185","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989191.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709418","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989200.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989179.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989218","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989206.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989197.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989158","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709415","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989215","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989173.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709394.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709385.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989164.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709385","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989161","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709412","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709379","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989212.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989167","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989200","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989182.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709382","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989170","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989218.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989194","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989188.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709412.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709406.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989164","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989188","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989221","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709409","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709421.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709400.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709418.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989191","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989230","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989173","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989197","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709406","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989206","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989194.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989203.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989176.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989209.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989221.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989161.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709388.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709403","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989158.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709379.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989230.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989203","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709391.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709397.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989170.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989167.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709382.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709397","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.23709406","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989176.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989191.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989200.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989206.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989218","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709421.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989185","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989161","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709397","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989215","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989158","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709403","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.6749782.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989221.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989212.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989182","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709394","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989218.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989212","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989179","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989167.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709412","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709412.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709388.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709379","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709418.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989161.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709409","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709403.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989176","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989209","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989170.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709391.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709397.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989194.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989185.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709418","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989179.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709424.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989173.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989203.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989206","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989158.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709409.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989230","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989197","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709382.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989173","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709385","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709379.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989203","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709415","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989230.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709382","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989209.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989194","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989170","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989215.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989167","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989200","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709424","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.6749782.v2","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709415.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709391","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989164.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709400","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989191","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709385.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989221","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989188","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709400.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709406.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709394.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.6749782","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989197.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989164","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709421","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23709388","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989188.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23989182.v1","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,18]]}}}